尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Roth David, Directeur Médical. Director active across 1 company, notably Syros Pharmaceuticals, Inc.. Cumulatively, 10 filings have been logged. Split: 0 buy · 5 sells. Total volume traded: €2k. History available since 18 November 2024. The latest transaction was disclosed on 18 November 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Roth David is Directeur Médical and Chief Medical Officer at Syros Pharmaceuticals, Inc. He has 10 filings in total, and among the recent sampled filings, the transactions are sales, with a total amount of EUR 2262 between 2022-04-04 and 2024-11-20.